Atlas Arteria Limited (ASX:ALX)
Australia · Delayed Price · Currency is AUD 4.800
-0.120 (-2.44%)
At close: Feb 27, 2026
Atlas Arteria Income Statement
Financials in millions AUD. Fiscal year is January - December.
Millions AUD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 158.9 | 145 | 133.2 | 116.7 | 100.66 |
Other Revenue | 1.1 | 0.9 | 0.8 | 1.5 | - |
| 160 | 145.9 | 134 | 118.2 | 100.66 | |
Revenue Growth (YoY) | 9.66% | 8.88% | 13.37% | 17.43% | -5.62% |
Cost of Revenue | 61.8 | 41.5 | 38.3 | 46.6 | 48.08 |
Gross Profit | 98.2 | 104.4 | 95.7 | 71.6 | 52.57 |
Selling, General & Admin | 21 | 9.9 | 8.1 | 7.3 | 4.75 |
Amortization of Goodwill & Intangibles | 69.8 | 68.8 | 67.4 | 64.3 | 60.04 |
Other Operating Expenses | 27.6 | 31.2 | 23.5 | 18.9 | 11.12 |
Operating Expenses | 120.5 | 111.6 | 100.8 | 92.4 | 77.35 |
Operating Income | -22.3 | -7.2 | -5.1 | -20.8 | -24.78 |
Interest Expense | -97.4 | -95.8 | -95 | -89 | -81.93 |
Interest & Investment Income | 18.1 | 17.7 | 18.1 | 17 | - |
Earnings From Equity Investments | 270.8 | 306.9 | 325.6 | 336.4 | 284.05 |
Currency Exchange Gain (Loss) | -0.8 | -1.4 | -1.5 | 4.4 | 1.04 |
Other Non Operating Income (Expenses) | 21.4 | 52 | 17.9 | 9.6 | 0.63 |
EBT Excluding Unusual Items | 189.8 | 272.2 | 260 | 257.6 | 179.02 |
Merger & Restructuring Charges | - | - | - | -13.4 | - |
Gain (Loss) on Sale of Investments | - | 31.1 | - | - | - |
Other Unusual Items | - | - | - | - | -51.09 |
Pretax Income | 189.8 | 303.3 | 260 | 244.2 | 127.93 |
Income Tax Expense | 8 | 3.1 | 3.7 | 3.2 | -35.77 |
Earnings From Continuing Operations | 181.8 | 300.2 | 256.3 | 241 | 163.7 |
Minority Interest in Earnings | 77.7 | 35.7 | 67.2 | 25.9 | 19.51 |
Net Income | 259.5 | 335.9 | 323.5 | 266.9 | 183.21 |
Net Income to Common | 259.5 | 335.9 | 323.5 | 266.9 | 183.21 |
Net Income Growth | -22.75% | 3.83% | 21.21% | 45.68% | - |
Shares Outstanding (Basic) | 1,451 | 1,451 | 1,451 | 1,084 | 959 |
Shares Outstanding (Diluted) | 1,453 | 1,453 | 1,453 | 1,086 | 960 |
Shares Change (YoY) | 0.03% | 0.01% | 33.79% | 13.08% | 4.04% |
EPS (Basic) | 0.18 | 0.23 | 0.22 | 0.25 | 0.19 |
EPS (Diluted) | 0.18 | 0.23 | 0.22 | 0.25 | 0.19 |
EPS Growth | -22.57% | 3.60% | -9.36% | 28.80% | - |
Free Cash Flow | 87.6 | 92.1 | 83.9 | 73.4 | 46.04 |
Free Cash Flow Per Share | 0.06 | 0.06 | 0.06 | 0.07 | 0.05 |
Dividend Per Share | 0.400 | 0.400 | 0.400 | 0.400 | 0.360 |
Dividend Growth | - | - | - | 11.11% | 50.00% |
Gross Margin | 61.38% | 71.56% | 71.42% | 60.58% | 52.23% |
Operating Margin | -13.94% | -4.93% | -3.81% | -17.60% | -24.61% |
Profit Margin | 162.19% | 230.23% | 241.42% | 225.80% | 182.02% |
Free Cash Flow Margin | 54.75% | 63.13% | 62.61% | 62.10% | 45.74% |
EBITDA | 49.6 | 63.3 | 64.1 | 45.4 | 36.71 |
EBITDA Margin | 31.00% | 43.39% | 47.84% | 38.41% | 36.47% |
D&A For EBITDA | 71.9 | 70.5 | 69.2 | 66.2 | 61.48 |
EBIT | -22.3 | -7.2 | -5.1 | -20.8 | -24.78 |
EBIT Margin | -13.94% | -4.93% | -3.81% | -17.60% | -24.61% |
Effective Tax Rate | 4.21% | 1.02% | 1.42% | 1.31% | - |
Revenue as Reported | 160 | 145.9 | 134 | 118.2 | - |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.